Carl Zeiss Meditec AG Stock: price and insider trades · Germany
2 insiders bought €124k of shares over the last 90 days, the latest by Pecher, Andreas, filed 10 Sept 2026.
Carl Zeiss Meditec AG: what insiders have been doing
This page follows insider dealings at Carl Zeiss Meditec AG as filed with BaFin, a company from the Health Care sector based in Jena, Germany. The group dates from 2002. In the past year (9 November 2025 to 9 November 2026), 3 filings came from 3 insiders.
No insider sold shares on the market over the period. Instead, the filings list 3 purchases totalling €176k, made by 3 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €104k, the purchase published on 7 September 2026 by Wehmer, Justus Felix is the largest of the period (0.0033% of market cap). Those buying include 2 senior executives and 1 board member.
In the case of 1 purchase, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 10 September 2026, 59 days ago. Between a trade and the moment it shows up on BaFin, the median delay is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19).
Compared with its exchange (290 companies, median 5 filings), a count of 3 filings is below the norm. Since 2026, the database holds 3 purchases and no sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from BaFin. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +6.6%Entry €30.50 · Close 12 Oct 2026 €32.50
- +5.6%Entry €30.78 · Close 12 Oct 2026 €32.50
- +24.9%Entry €26.02 · Close 12 Oct 2026 €32.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Carl Zeiss Meditec AG Underperform (bearish), based on 15 analysts. Average price target: €26.89.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended September 2025 · cache
- 656 shares@ €30.850.0007% mcap100.0% of flowShareTradegateISIN DE0005313704BAFIN:40002012-66d0ad8ec8b4Canonical exit: 8 Dec 2026 (T+90)
- 3,199.52 shares@ €32.370.0038% mcap100.0% of flowShareXETRAISIN DE0005313704BAFIN:40002012-3027e3e79834Canonical exit: 3 Dec 2026 (T+90)
- 2,000 shares@ €25.90100.0% of flowShareXetraISIN DE0005313704BAFIN:40002012-d3f88076c8c2Canonical exit: 26 Aug 2026 (T+90)
3 of 3 declarations
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG is a company specializing in medical technology, providing innovative solutions for the diagnosis and treatment of eye diseases. It is listed on the Frankfurt Stock Exchange (XETR).
